These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 3971384

  • 1. Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer.
    Frankfurt OS, Chin JL, Englander LS, Greco WR, Pontes JE, Rustum YM.
    Cancer Res; 1985 Mar; 45(3):1418-23. PubMed ID: 3971384
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
    Jack GS, Cookson MS, Coffey CS, Vader V, Roberts RL, Chang SS, Smith JA, Shappell SB.
    J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Correlation of protein expression, Gleason score and DNA ploidy in prostate cancer.
    Lexander H, Palmberg C, Hellman U, Auer G, Hellström M, Franzén B, Jörnvall H, Egevad L.
    Proteomics; 2006 Aug; 6(15):4370-80. PubMed ID: 16888723
    [Abstract] [Full Text] [Related]

  • 7. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G, Lindholm K, Falkmer U, Abrahamsson PA.
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [Abstract] [Full Text] [Related]

  • 8. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies.
    Takahashi S, Qian J, Brown JA, Alcaraz A, Bostwick DG, Lieber MM, Jenkins RB.
    Cancer Res; 1994 Jul 01; 54(13):3574-9. PubMed ID: 8012984
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T, Amunni G, Molino C, Carriero C, Rapi S, Branconi F, Marchionni M, Taddei G, Scarselli G.
    Cancer; 2007 Mar 01; 109(5):882-90. PubMed ID: 17262824
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer.
    Badalament RA, O'Toole RV, Young DC, Drago JR.
    Cancer; 1991 Jun 15; 67(12):3014-23. PubMed ID: 1710533
    [Abstract] [Full Text] [Related]

  • 14. Factors that influence the measurement of prostate cancer DNA ploidy and proliferation in paraffin embedded tissue evaluated by flow cytometry.
    So MJ, Cheville JC, Katzmann JA, Riehle DL, Lohse CM, Pankratz VS, Sebo TJ.
    Mod Pathol; 2001 Sep 15; 14(9):906-12. PubMed ID: 11557788
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tumor spread and DNA content in human renal cell carcinoma.
    Ljungberg B, Stenling R, Roos G.
    Cancer Res; 1988 Jun 01; 48(11):3165-7. PubMed ID: 3365699
    [Abstract] [Full Text] [Related]

  • 17. Near tetraploid prostate carcinoma. Methodologic and prognostic aspects.
    Forsslund G, Nilsson B, Zetterberg A.
    Cancer; 1996 Oct 15; 78(8):1748-55. PubMed ID: 8859188
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C, Bocsi J, Bartha I, Math J, Balazs G.
    Anticancer Res; 2002 Oct 15; 22(6B):3737-41. PubMed ID: 12552986
    [Abstract] [Full Text] [Related]

  • 19. Relationship between DNA ploidy and functional estrogen receptors in operable prostate cancer.
    Nativ O, Umehara T, Colvard DS, Therneau TM, Farrow GM, Spelsberg TC, Lieber MM.
    Eur Urol; 1997 Oct 15; 32(1):96-9. PubMed ID: 9266239
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.